NCM Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Sell |
3,616
-100
| -3% | -$8.29K | 0.12% | 144 |
|
|
2025
Q1 | $301K | Sell |
3,716
-50
| -1% | -$4.06K | 0.14% | 142 |
|
|
2024
Q4 | $339K | Hold |
3,766
| – | – | 0.15% | 134 |
|
|
2024
Q3 | $372K | Hold |
3,766
| – | – | 0.18% | 122 |
|
|
2024
Q2 | $349K | Hold |
3,766
| – | – | 0.18% | 119 |
|
|
2024
Q1 | $357K | Buy |
3,766
+21
| +0.6% | +$1.99K | 0.2% | 116 |
|
|
2023
Q4 | $334K | Sell |
3,745
-50
| -1% | -$4.46K | 0.2% | 117 |
|
|
2023
Q3 | $277K | Hold |
3,795
| – | – | 0.2% | 116 |
|
|
2023
Q2 | $316K | Hold |
3,795
| – | – | 0.22% | 115 |
|
|
2023
Q1 | $289K | Buy |
3,795
+45
| +1% | +$3.43K | 0.22% | 118 |
|
|
2022
Q4 | $311K | Hold |
3,750
| – | – | 0.21% | 130 |
|
|
2022
Q3 | $297K | Hold |
3,750
| – | – | 0.22% | 131 |
|
|
2022
Q2 | $279K | Hold |
3,750
| – | – | 0.2% | 142 |
|
|
2022
Q1 | $337K | Hold |
3,750
| – | – | 0.21% | 139 |
|
|
2021
Q4 | $420K | Buy |
+3,750
| New | +$420K | 0.37% | 90 |
|